+ Filter
Loading...
CD22 & CD79B
Loading...Anti-CD22 & CD79B Products
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
- Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) (TAB-183-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
- Human Anti-CD22 Recombinant Antibody (HPAB-0199-LSX) (HPAB-0199-LSX)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ELISA, FC
- Human Anti-CD22 Recombinant Antibody (TAB-1722CL) (TAB-1722CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Anti-Human CD22 Recombinant Antibody (RFB4) (TAB-1728CL)
-
- Application: IF, FC
- Human Anti-CD22 Recombinant Antibody (clone MJ-7) (HPAB-0206-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, FC, WB
- Human Anti-CD22 Recombinant Antibody (TAB-1717CL) (TAB-1717CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (clone HuLL2) (HPAB-0205-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, FC
- Rat Anti-CD22 Recombinant Antibody (clone 2D6) (NEUT-315CQ)
-
- Species Reactivity: Mouse
- Type: Rat IgG1, κ
- Application: Block
- Human Anti-CD22 Recombinant Antibody (TAB-1716CL) (TAB-1716CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (clone RFB4-PE38) (HPAB-0204-LSX)
-
- Derivation: Chimeric
- Species Reactivity: Human
- Type: Chimeric IgG
- Application: Cyt, RIA, FuncS, FC, PK, Neut, ELISA
- Human Anti-CD22 Recombinant Antibody (TAB-1715CL) (TAB-1715CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1729CL) (TAB-1729CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: IF, FC
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-001LC-S(P)) (TAB-001LC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
- Anti-Human CD22 Recombinant Antibody scFv Fragment (VM1000) (TAB-002LC-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, SPR
- Human Anti-CD22 Recombinant Antibody (TAB-1724CL) (TAB-1724CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: Inhib
- Human Anti-CD22 Recombinant Antibody (TAB-1725CL) (TAB-1725CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: Block, Cyt, ELISA, FuncS
- Mouse Anti-CD22 Recombinant Antibody (HPAB-0201-LSX) (HPAB-0201-LSX)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FuncS, ELISA, WB, FC, RIA
- Human Anti-CD22 Recombinant Antibody (HPAB-0202-LSX) (HPAB-0202-LSX)
-
- Derivation: Chimeric
- Species Reactivity: Human
- Type: Chimeric IgG
- Application: ELISA, WB, FC, RIA
- Human Anti-CD22 Recombinant Antibody (HPAB-0203-LSX) (HPAB-0203-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human, Cynomolgus monkey
- Type: Humanized IgG1
- Application: ELISA, WB, FC, RIA, FuncS
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2) (TAB-0196CL-F(E))
-
- Application: ELISA, In vivo
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2-Cys) (TAB-0197CL-F(E))
-
- Application: ELISA, In vivo
- Human Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-001LC-F(E)) (TAB-001LC-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
- Anti-Human CD22 Recombinant Antibody Fab Fragment (VM1000) (TAB-002LC-F(E))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, SPR
- Human Anti-CD22 Recombinant Antibody (HPAB-0195-LSX) (HPAB-0195-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: Apop, Cyt, FC, WB, Inhib, FuncS, IF, ELISA
- Mouse Anti-CD22 Recombinant Antibody (HPAB-0196-LSX) (HPAB-0196-LSX)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC, IP, RIA
- Human Anti-CD22 Recombinant Antibody (HPAB-0197-LSX) (HPAB-0197-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, FC, FuncS
- Mouse Anti-CD22 Recombinant Antibody (HPAB-0198-LSX) (HPAB-0198-LSX)
-
- Species Reactivity: Human, Cynomolgus monkey
- Type: Mouse IgG
- Application: ELISA, WB, IF, FC, SPR
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB, FC, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: IF, FC
- Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS
- Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB
- anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
- Mouse Anti-Human CD22 Recombinant Antibody Fab Fragment (TAB-003LC-F(E))
-
- Application: FC
- Anti-Human CD22 Recombinant Antibody Fab Fragment (TAB-004LC-F(E))
-
- Application: FC
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-005LC-F(E)) (TAB-005LC-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FC
- Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-Sap (AGTO-G077S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Mouse Anti-Human CD22 Recombinant Antibody scFv Fragment (TAB-003LC-S(P))
-
- Application: FC
- Anti-Human CD22 Recombinant Antibody scFv Fragment (TAB-004LC-S(P))
-
- Application: FC
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-005LC-S(P)) (TAB-005LC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
- Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) (TAB-1714CL)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
-
- Derivation: Phage display library
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC, ICC, IP, FC
-
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin
- Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (SN8)-vc-MMAE ADC (RG7596) (ADC-L029)
-
- Target: CD79b
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (clone ch10D10)-BMPEO-DM1 ADC (ADC-055CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone ch10D10)-MC-MMAF ADC (ADC-054CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Classification: Fc glycosylation
- Glycosylation site: Asn297 in Fc region
- Anti-CD79b (clone ch10D10)-MC-vc-PAB-MMAE ADC (ADC-056CL)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (clone huMA79b.v18)-MC-MMAF ADC (ADC-048CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone huMA79b.v18)-BMPEO-DM1 ADC (ADC-049CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone huMA79b.v18)-MCvcPAB-MMAE ADC (ADC-050CL)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone hLL2)-SN-38 ADC (ADC-124CL)
-
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD79b (clone huMA79b.v28)-MC-MMAF ADC (ADC-051CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone huMA79b.v28)-BMPEO-DM1 ADC (ADC-052CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (RFB4)-mcc-DM1 ADC (ADC-028LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (10F4)-AcBut-Calicheamicin ADC (ADC-029LCT)
-
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin
- Anti-CD79b (Polatuzumab)-vc-MMAE ADC (ADC-087LCT)
-
- Target: CD79b
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
- Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD79b-vc-MMAE ADC (ADC-034LZY)
-
- Target: CD79b
- Linker: VC(Valine-citrulline)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
-
- Target: CD22
- Drug: saporin
- Anti-CD22 (clone 10F4v3)-MCC-DM1 ADC (ADC-194LZY)
-
- Target: CD22
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22 (clone 10F4v3)-mc-vc-PABC-MMAE ADC (ADC-195LZY)
-
- Target: CD22
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD79b-MCC-DM1 ADC (ADC-084LZY)
-
- Target: CD79b
- Linker: MCC (4-(Nmaleimidomethyl)cyclohexane-1 carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD79b (clone SN8)-SPP-DM1 ADC (ADC-201LZY)
-
- Target: CD79b
- Linker: SPP(N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD79b (clone SN8)-MCC-DM1 ADC (ADC-202LZY)
-
- Target: CD79b
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD79b-mc-MMAF ADC (ADC-085LZY)
-
- Target: CD79b
- Linker: mc(maleimidocaproyl)
- Drug: MMAF(monomethyl auristatin F)
- Anti-CD79b (clone SN8)-mc-vc-PABC-MMAE ADC (ADC-203LZY)
-
- Target: CD79b
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD79b (clone SN8)-mc-MMAF ADC (ADC-204LZY)
-
- Target: CD79b
- Linker: mc(maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- THIO-Anti-CD79b (Polatuzumab)-MC-VC-PABC-MMAE ADC (ADC-088LCT)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79 (bSN8)-mcc-DM1 ADC (ADC-089LCT)
-
- Target: CD79b
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-cyCD79b (clone 10D10)-MCC-DM1 ADC (ADC-216LZY)
-
- Target: cyCD79b
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate))
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD79b (clone ch2F2)-SMCC-DM1 ADC (ADC-202CL)
-
- Target: CD79b
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone hu2F2.D7)-SMCC-DM1 ADC (ADC-203CL)
-
- Target: CD79b
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone hu2F2.D7)-BMPEO-DMl ADC (ADC-204CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone hu2F2.D7)-MC-MMAF ADC (ADC-205CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone hu2F2.D7)-MCvcPAB-MMAE ADC (ADC-206CL)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (clone ch2F2)-MC-MMAF ADC (ADC-207CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone ch2F2)-MC-MMAF ADC (ADC-208CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
CD22 (CD22 Molecule) is a Protein Coding gene. Diseases associated with CD22 include refractory hematologic cancer and colon lymphoma. Among its related pathways are Immune System and Downstream signaling events of B Cell Receptor (BCR). GO annotations related to this gene include carbohydrate binding. An important paralog of this gene is VCAM1.
The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component.


BCR Signaling Pathway
